ACCUSTEM SCIENCES, INC. Proceeds from Common Stock Issued
ACCUSTEM SCIENCES, INC. (ACUT) reported Proceeds from Common Stock Issued of $2.68 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2024-03-22
- ACCUSTEM SCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $0.00.
- ACCUSTEM SCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2022-09-30 was -$187.00.
- ACCUSTEM SCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2022-06-30 was $187.00.
- ACCUSTEM SCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2022-03-31 was $2.68M.
- ACCUSTEM SCIENCES, INC. proceeds from issuance of common stock for fiscal 2022 was $2.68M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$187.00 derived: sum of 2 quarters · filed 2024-03-22 | $0.00 derived: sum of 3 quarters · filed 2024-03-22 | $2.68M 10-K · filed 2024-03-22 |
| 2022-09-30 | -$187.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $2.68M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $187.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.68M 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $2.68M 10-Q · filed 2023-05-05 |